ViiV Aims To Extend HIV Drug Durations With Halozyme’s Technology
Duo Will Expand Body’s Intake Capacity For Injected Medicines
ViiV Healthcare’s head of R&D tells Scrip that extending the durations of its long acting HIV treatments is possible using drug delivery technology from Halozyme Therapeutics to expand the body’s capacity to absorb injected medicines.
